Russian president Vladimir Putin in a video conference meeting at his Moscow residence, Oct. 14, 2020. Putin says a second Covid-19 vaccine has been approved after the US was dubious of the first. (Alexei Druzhinin, Sputnik, Kremlin Pool Photo via AP)

Covid-19 roundup: Rus­sia ap­proves sec­ond vac­cine, Putin says; Ad­vo­ca­cy groups ask WTO to waive patent rights

Rus­sia has ap­proved a sec­ond Covid-19 vac­cine, pres­i­dent Vladimir Putin an­nounced Wednes­day. Like its first, the coun­try’s new vac­cine did not un­der­go large-scale tri­als be­fore ap­proval.

Putin said that the vac­cine comes from the Siber­ian biotech Vec­tor State Vi­rol­o­gy and Biotech­nol­o­gy Cen­ter, al­so a for­mer So­vi­et bioweapons re­search lab, ac­cord­ing to the Wall Street Jour­nal. The in­sti­tu­tion plans to be­gin a 40,000-pa­tient tri­al soon.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.